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ABSTRACT The interactions established at the 5'-splice
site during spliceosome assembly are likely to be important for
both precise recognition of the upstream intron boundary and
for positioning this site in the active center of the spliceosome.
Definition of the RNA-RNA and the RNA-protein interac-
tions at the 5' splice site would be facilitated by the use of a
small substrate amenable to modification during chemical
synthesis. We describe a trans-splicing reaction performed in
Saccharomyces cerevisiae extracts in which the 5' splice site and
the 3' splice site are on separate molecules. The RNA con-
tributing the 5' splice site is only 20 nucleotides long and was
synthesized chemically. The trans-splicing reaction is accu-
rate and has the same sequence, ATP, and Mg2+ requirements
as cis-splicing. We also report how deoxy substitutions around
the 5'-splice site affect trans-splicing efficiency.
The recognition of the 5'-splice site (5'SS) and its positioning
in the spliceosome active site appears to be a multistep reaction
(for review, see refs. 1-4). At least three small nuclear RNAs
(snRNAs) have been implicated in this process. Ul snRNA is
required for the initial intron 5'-end recognition, which is
accomphished primarily by Watson-Crick base pairing (5-7).
Subsequently, U5 snRNA contributes to the recognition of the
3' end of the upstream exon, and this interaction also involves
base-pairing interactions (8, 9). Before the first step of the
splicing reaction, the U6 snRNA displaces Ul at the 5'SS to
establish an interaction important for 5'SS definition (10-15).
A number of proteins have also been reported to interact with
the 5'SS (for review, see ref. 4). Many details of these
RNA-RNA and RNA-protein interactions are not known. For
example, although the first three bases of introns are com-
pletely conserved among the known intron sequences and have
been placed in close proximity to A51 in U6 snRNA by
crosslinking experiments (ref. 15; C.-H. Kim and J.N.A.,
unpublished results), it is not clear whether U6 specifically
recognize these nucleotides. Knowledge of the precise geom-
etry of the U5 and U6 snRNA interactions across the 5'SS
could contribute substantially to our understanding of the first
step of splicing by constraining the conformation of the
substrate.
A small chemically synthesized 5'SS substrate would allow
for easy RNA modifications. Introducing crosslinking deriva-
tives at specific positions or changing the hydrogen-bonding
potential or steric hindrance at particular sites would allow the
probing of many features of the interactions formed at the
5'SS. Hall and Konarska (16) found that a small RNA oligo-
nucleotide bearing the 5'SS consensus sequence can induce
assembly of ribonucleoprotein complexes containing the U2,
U4, U5, and U6 small nuclear ribonucleoproteins. Interest-
ingly, the interaction between this short 5'SS and the spliceo-
somal RNAs appears to have many features in common with
the interactions formed at the 5'SS during the splicing reaction
(17, 18). HeLa cell extracts can splice substrates in which the
5' and 3' splice sites are on separate RNA molecules (19-23).
In the trans-splicing reactions studied by Chiara and Reed
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(23), the donor site molecules contained between 45 and 129
nucleotides of upstream exon sequence but product formation
has been observed by these authors with as few as 4 nucleotides
of intronic sequence at the 5'SS.
In the present report, we describe trans-splicing reactions
performed in Saccharomyces cerevisiae crude extracts by using
a short donor site molecule synthesized chemically. The splic-
ing reaction is accurate, and this experimental system has
allowed us to probe the role of all of the 2'-OH groups in
consensus nucleotides at the 5'SS.
METHODS
RNA Preparation. The following RNA oligonucleotides
were synthesized chemically by using an Applied Biosystems
synthesizer: RNA1, 5'-AUGGAUUCUGGUAUGUUCUA-
3'; RNA1/int, 5'-AUGGAUUCUGAUAUGUUCUA-3';
RNA1/ex, 5'-AUGGAUUGAGGUAUGUUCUA-3'. All 2'-
deoxy-modified RNA oligonucleotides were synthesized chem-
ically. The plasmid construct for transcribing RNA2 was
generated as follows. The cloned yeast actin gene was used as
a template for a polymerase chain reaction (PCR) with the
oligonucleotides Act2 (5'-CGCCGGATCCCTAATACGACT-
CACTATAGGGTGATAAGTGATAG-3') containing a
BamHI restriction site (underlined) and the sequence of the T7
RNA polymerase promoter (in italic type) and ActR (5'-
CGCCGGAATTCCTTCATCACCAACGTAGGA-3') con-
taining an EcoRI restriction site (underlined). The PCR
product obtained with these two oligonucleotides contains the
104 nucleotides at the 3' end of the actin gene intron as well
as 163 nucleotides of the downstream exon. The PCR products
were phenol-extracted; the DNA was precipitated with ethanol
and digested with EcoRI and BamHI. After purification by
agarose gel electrophoresis, the PCR product was cloned in a
pUC19 plasmid vector containing EcoRI and BamHI ends.
The sequence of the cloned actin gene fragment was confirmed
by direct plasmid sequencing. For RNA2 synthesis, the plasmid
was linearized with EcoRI and used as template for in vitro
transcription using T7 RNA polymerase.
Trans-Splicing Reaction. 32p internally labeled RNA2 (80
fmol) and the indicated amount of RNA1 were incubated in 10
,ul containing 55 mM potassium phosphate (pH 7.20), 2.5 mM
MgCl2, 3 mM ATP, 2.5% (wt/vol) PEG (Mr 8000), 1 mM
spermidine, 1 mM dithiothreitol, and 60% (vol/vol) yeast
extract prepared as described (24). Incubation was at 16°C for
the indicated time. Reactions were stopped by addition of 1 p,l
of a mixture containing 5% (wt/vol) SDS, 100 mM EDTA,
proteinase K (100 ,ug/ml), and yeast tRNA (100 jig/ml). After
a 10-min incubation at 37°C, the reaction products were
extracted with phenol equilibrated with 0.1 M sodium acetate
(pH 5.2), and the RNA was precipitated with ethanol. Samples
were dissolved in denaturing buffer (8 M urea/1 mM EDTA),
heated 3 min at 80°C, and loaded on denaturing 6% polyacryl-
amide/7 M urea gels.
Products Analysis. Reaction products were isolated from
slices of the denaturing gel by elution in 0.3 M sodium
acetate/0.1% SDS/1 mM EDTA. The eluted RNA was phe-
Abbreviations: 55SS, 5'-splice site; snRNA, small nuclear RNA.
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nol-extracted and ethanol-precipitated. The isolated products
were used as templates in primer-extension reactions with
either one of the following DNA oligonucleotides: ActR2
(5'-ACATACCAGAACCGTTATCA-3') or ActR3 (5'-CT-
AAACATATAATATAGCAAC-3'). The Moloney murine
leukemia virus reverse transcriptase (Superscript, from BRL)
was used according to manufacturer's instructions. The spliced
exon product was amplified by PCR after the reverse tran-
scription, using the oligonucleotides ActR and ActF (5'-
CGCGCGGGATCCGGGATT-3') containing a BamHI site
(underlined). Thirty-five amplification cycles were performed:
denaturation for 1 min at 90°C, annealing for 1 min at 45°C,
and elongation for 1 min at 72°C. Annealing conditions were
changed during the course of the amplification: in the first 3
cycles, annealing was at 30°C for 1 min and for cycles 4-10,
annealing was at 35°C for1 min. The PCR product was digested
with the restriction enzymes EcoRI and BamHI and ligated to
a pUC19 plasmid vector. Five isolates were sequenced by using
the ActR2 primer.
RESULTS
For the trans-splicing reaction, we used two RNA substrates.
RNA1, the first molecule, was synthesized chemically and
consists of 10 nucleotides of exon sequence and 10 nucleotides
of intron sequence containing the consensus sequence for the
5'SS. RNA2, the second molecule, is a fragment of the actin
pre-mRNA containing the branch site, the 3SS, and the
downstream exon (Fig. IA). In the experiment shown in Fig.
1B, internally labeled RNA2 was incubated in yeast crude
extract, under different conditions, with an excess of unlabeled
RNA1. Several products appeared in a time-dependent man-
ner. Product formation required ATP and Mg2+ (Fig.1B, lanes
5 and 6). The identity of the first nucleotide of the intron is also
an important requirement: when, as 5'SS, RNA1/int was used,
which contains a G -- A mutation at the first intron nucleotide,
product formation was abolished (Fig. lB, lane 3). In contrast
a double mutation in the exon sequence just upstream of the
5'SS did not interfere with the reaction (Fig. IB, lane 4). These
requirements are identical to those found in normal cis-
splicing reactions. Extending the 5' exon up to 30 nucleotides
did not improve the reaction efficiency, but shortening the
exon to 3 nucleotides failed to support splicing (data not
shown).
To assess their identity, the individual products were puri-
fied from the denaturing gels and analyzed by reverse tran-
scription using different 5'-end-labeled primers. The product
labeled a in Fig. lB has the size expected for the ligated exons
and primer extension with an oligonucleotide complementary
to exon 2 supported this assignment (Fig. 2). To confirm the
identity of product a and examine the accuracy with which the
two exons are spliced, product a was purified from the
denaturing gel, reverse-transcribed with a primer complemen-
tary to exon 2, and amplified in a polymerase chain reaction
(PCR) by adding a primer complementary to the first 5 bases
of exon1 present on RNAI. The PCR product was cloned and
five clones were sequenced and found to be identical. Sequenc-
ing across the splice junction shows that the two exons are
spliced accurately (Fig. 3).
Based on electrophoretic mobility, product b is slightly
larger than the linear intron sequence of RNA2, while prod-
ucts c and d are slightly smaller. In primer-extension experi-
ments, RNA b gives the product predicted for the use of the
normal branch site (Fig. 2). Although less intense, a second
band,1 nucleotide longer, is also visible. These results indicate
that product b is the branched intron generated in the splicing
reaction and that branch site selection on RNA2 appears to be
accurate. Also consistent with this conclusion is the lack of
detectable extension products from a primer complementary
to exon 2 (Fig. 2); furthermore, product b was not detected
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FIG. 1. Invitro trans-splicing. (A) The trans-splicing substrates are
schematically shown in comparison with the actin pre-mRNA. Also
shown are the sequences of RNA1, containing the wild-type 5'SS
(WT) and two mutant versions (ex and int); the exon sequence is
shown in uppercase type. (B Left) Internally labeled RNA2 was
incubated for the indicated time in the presence of 5,uM RNA1;
reaction products are indicated a-e. (B Right) Reactions were incu-
bated for 2 hours as above (lane 2). All other reactions were as
described in Methods but with the following variations. Lanes: 1, RNA1
was omitted from the reaction; 3, mutant 5'SS containing the GIA
mutation (oligoribonucleotide RNA1/int, 5,uM); 4, mutant RNA1
containing two mutations in the 5' exon sequence (oligoribonucleotide
RNA1 /ex, 5,uM); 5, no ATP; 6, MgCl2 was omitted and1 mM EDTA
was added to the reaction mixture. Numbers on the side of the gels
correspond to the mobility of size markers in bases.
when RNA2 was3'-end-labeled but was detected when it was5'-end-labeled (data not shown). Primer extension of RNA c
gives the same products observed in the reaction with RNA b.
Based both on the kinetics of formation of products c, d, and
e and the results obtained with end-labeled substrates (data
not shown), we believe RNAs c, d, and e represent degradation
products of the branched intron.
We have investigated the dependence of the reaction rate on
the RNA1 concentration. At the highest RNAI concentrations
(3-7,tM), formation of the spliced exon products reaches a
plateau after approximately 2 hours (Fig. 4). The maximum
amount of spliced product corresponds to about 6.5% of the
labeled RNA2 substrate. The rate vs. time relation appears to
be linear up to about 90 min of incubation. Therefore, product
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FIG. 2. Identification of the trans-splicing products by primer
extension. Two primers were used: 3' exon primer (oligonucleotide
ActR2) and intron primer (oligonucleotide ActR3). The trans-splicing
products used as template for the primer-extension reactions are
indicated. The same primers were used to generate the sequencing
ladders. (Left) Sequence of cloned spliced exons is shown. (Right)
Sequence of cloned RNA2 cDNA is shown. The main primer-
extension products are indicated by arrows. Circled base (Right) is the
canonical branch site used during RNA splicing of the actin pre-
mRNA.
accumulation over the first 90 min was used to estimate the
reaction rates at different RNA1 concentrations. By plotting
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FIG. 4. Trans-splicing reaction rate. Trans-splicing reaction effi-
ciency at various RNA1 concentrations as function of time was
estimated by resolving the reaction products on denaturing gels and
analyzing the gel by Phosphorlmager (Molecular Dynamics). RNA1
concentrations used are the following: A, 0.2 ,uM; *, 1 ,uM; *, 3 ,uM;
*, 5 ,iM; 0, 7 ,uM. The lines represent linear fitting of the first 90 min
of reaction.
the results in an Eadie-Hofstee plot, we estimated the Km
value for RNA1 to be 1.6 ,uM. The purpose of this estimate
is not a detailed analysis of the kinetics parameters of the
reaction but the definition of a range of RNA1 concentrations
that are below saturation (see also Discussion).
The effect of multiple and single 2'-deoxy substitutions at
the 5'SS was then investigated. In these experiments, the
amount of RNA1 used was 1.5 ,uM, slightly below the esti-
mated Km; under these conditions, the assay is expected to be
more sensitive to the effect of the deoxynucleotide substitu-
tions. All of the modified substrates were still converted into
products (Fig. 5). 2'-Deoxy substitution at all the nucleotides
in exon 1 reduces the efficiency of the reaction by about 70%.
Similar results were observed 2'-deoxy substitution at all the
nucleotides in the intron sequence at the 5'SS. Single substi-
tutions from positions -3 to + 10 had smaller effects. A 2-fold
reduction in trans-splicing efficiency was observed for 2'-deoxy
4-4
0
5'- exon
FIG. 3. Splice junction sequence. The spliced exons were reverse-
transcribed and the resulting cDNA was amplified by PCR, cloned, and
sequenced. The splice junction is indicated by the arrow.
single 2'-deoxy substitutions
FIG. 5. Effect of 2'-deoxy substitution at the 5'SS. The effect on
trans-splicing of 2'-deoxy substitutions in RNA1 was evaluated in
reactions containing 1.5 ,UM RNA1. Reactions were incubated 2 hours;
products were resolved on denaturing polyacrylamide gels and quan-
titated by PhosphorImager (Molecular Dynamics) analysis. Results are
shown after normalization to the splicing efficiency of the unmodified
RNA1 (wt). Each bar represents the average of the results obtained in
three experiments.
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substitution at positions -1, +1, and +2. The only position
where a single 2'-deoxy substitution has an appreciable effect
is position +5, where reaction efficiency was reduced almost
65%.
DISCUSSION
Trans-splicing has been demonstrated in trypanosomes (for
review, see ref. 25), in nematodes (26), and in plant organelles
(27). Mammalian extracts have also been reported to catalyze
trans-splicing reactions provided a complementary sequence is
present on the two substrates forming the 5' and 3' splice sites
(19, 20), an enhancer sequence is present in the molecule
containing the 3' splice site (22, 23), or the molecule contain-
ing the 3' splice site also has a 5'SS downstream of the exon
sequence (23). In addition, it has recently been shown that
trans-splicing can be detected in cultured mammalian cells
(28). We have investigated the ability of yeast crude extracts to
perform trans-splicing by using as a 5'SS substrate, a small
RNA oligonucleotide. Short RNA oligonucleotides have been
shown to form specific interactions with spliceosomal compo-
nents in HeLa extract (16-18). Although RNA oligonucleo-
tides of the same size (11 nucleotides) used by Konarska and
colleagues (19) did not appear to be substrate for the trans-
splicing reaction in our system, slightly longer RNA molecules
could be trans-spliced in yeast extracts. The data reported in
the present work represent an example of the in vitro trans-
splicing reaction in S. cerevisiae. The small size of the substrates
makes this an attractive system for studies in which chemically
modified RNAs are used as splicing substrates to probe
RNA-RNA and RNA-protein interactions at the splice sites.
Compared to the in vitro cis-splicing reaction, which usually
reaches a plateau of 50-80% spliced precursor in approxi-
mately 40 min at 16°C, trans-splicing appears to be slower and
relatively inefficient, reaching a plateau of 6-8% spliced
precursor in about 2 hours. The reaction, however, is accurate
in terms of branch site selection and exon splice junction. In
contrast with studies performed in mammalian cells, our RNA
substrates do not contain any obvious complementarity nor do
they contain known enhancer sequences.
We have estimated the Km value for the RNA1 substrate by
titrating the RNA1 and measuring the change in reaction rate.
The crude estimate obtained (Km - 1.6 ,uM) was a useful
reference for the experiments in which the effect of modifi-
cations in RNA1 was studied, since saturating amounts of
RNA1 may lead to underestimation of the effect of modifica-
tions. We tested the effect of 2'-deoxy substitutions around the
5'SS. By analogy with what has been observed in ribozymes,
the 2'-OH group could play an important role by activating the
neighboring 3-oxygen leaving group at the 5'SS (29), by
coordinating metal cations (30), or by participating in RNA-
RNA tertiary interactions (31, 32). From our results, at all of
the positions we have tested, the 2'-OH group is not an
absolute requirement: all the multiple and single 2'-deoxy
substitution were compatible with trans-splicing. However,
small but reproducible effects were observed at some posi-
tions. Single 2'-deoxy substitution at positions - 1 to +2
reduced the reaction efficiency by about 2-fold and a 3-fold
reduction is observed by removing the 2'-OH at position +5.
The effect of 2'-deoxy substitution at position -1 has previ-
ously been investigated in cis-splicing reactions by Moore and
Sharp (33), who reported absolutely no effect on in vitro
splicing for the 2'-deoxy substitution at position -1. The
slightly different result we have obtained is likely a conse-
quence of the differences in the experimental system used: our
experiments were performed under subsaturating 5'SS con-
centration that probably makes the assay more sensitive com-
pared to the cis-splicing reaction used by Moore and Sharp
(33). It is also possible that the rate limiting step in yeast
trans-splicing may be not the same as in mammalian cis-
splicing. The small effect we have observed for the 2'-OH
group removal at position -1 supports the conclusion by
Moore and Sharp (33) that this group is unlikely to play the
crucial role in catalysis proposed for the 2'-OH group at -1 in
the self splicing Tetrahymena ribozyme (29). The small effects
(2- to 3-fold) we have observed for the 2'-deoxy substitutions
at positions -1, +1, +2, +3, and +5 have the magnitude
expected for duplex destabilization by single deoxy substitution
(34); if this is the case these substitutions may interfere with the
trans-splicing reaction by destabilizing the duplex formed by
the 5'SS with Ul and U6 snRNAs. However, we cannot
completely rule out that at positions -1, +1, +2, +3, and +5,
the 2'-OH group may be involved in tertiary interactions with
other spliceosomal components.
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